Skip to content
Review

Artificial intelligence in antimicrobial stewardship: prediction, clinical applications, and implementation challenges.

Jul 2026 · Clinical Microbiology and Infection · 1 citation · 51 references
Medicine

TL;DR

Current applications of AI in antimicrobial stewardship are reviewed, with emphasis on resistance prediction and risk stratification, empiric therapy selection, diagnostic stewardship, antimicrobial optimization, and implementation challenges in clinical practice.

Abstract

Background

Antimicrobial resistance (AMR) continues to threaten modern infectious diseases practice. Antimicrobial stewardship programs (ASPs) remain central to optimizing antimicrobial use, yet stewardship has become increasingly challenging because of rising clinical complexity, expanding data sources, and persistent workforce and analytic constraints. Artificial intelligence (AI) may strengthen stewardship by integrating clinical, microbiologic, and contextual data to support more timely and individualized decision-making.

Objectives

To review current applications of AI in antimicrobial stewardship, with emphasis on resistance prediction and risk stratification, empiric therapy selection, diagnostic stewardship, antimicrobial optimization, and implementation challenges in clinical practice. SOURCES Relevant studies evaluating AI and machine learning approaches for AMR prediction, diagnostic stewardship, antimicrobial optimization, and clinical implementation were reviewed. CONTENT AI-based models have been developed to predict AMR and identify patients at risk for multidrug-resistant infections using electronic health record data. These approaches may support empiric therapy selection and patient-level risk stratification, although important methodological limitations remain, including heterogeneous prediction targets, data leakage, and limited external validation. AI applications also extend to diagnostic stewardship, including optimization of blood culture use, rationalization of molecular diagnostics, and support for interpretation of microbiologic results. In the therapeutic phase, AI may support de-escalation, intravenous-to-oral conversion, duration-of-therapy reassessment, and prioritization of stewardship review, aligning clinical decisions with antimicrobial stewardship goals. However, successful implementation depends not only on model performance but also on effective integration into clinical workflows, interpretability, governance, and clinician uptake. IMPLICATIONS AI has the potential to enhance antimicrobial stewardship by enabling more precise, scalable, and workflow-integrated decision support. Future work should prioritize prospective and multicenter evaluation, careful implementation in routine care, and governance frameworks that address safety, transparency, equity, and clinician oversight. AI should be viewed as a tool to augment ASP expertise rather than replace clinical judgment.

View source

Similar papers

Review Open access Aug 2026

Artificial Intelligence and Bioengineering Approaches for Antimicrobial Resistance Prediction

AI has considerable potential to support AMR prediction and antimicrobial stewardship, but broader implementation will require rigorous validation, integration into clinical workflows, continuous monitoring and demonstration of clinical benefit.

Oana Frandeș, L. Azamfirei, Oana-Elena Branea et al. · 0 citations
#small language model Review Open access Sep 2026

Artificial Intelligence in Antimicrobial Stewardship: Transforming Antibiotic Prescribing in the Digital Era

Current evidence supports AI as a promising but clinically unproven adjunct to AMS, but the literature’s emphasis on algorithmic accuracy over demonstrated clinical effectiveness means AI should not yet be treated as validated stewardship infrastructure.

Bamidele Ilerioluwa Olamide, Olohitai Peace Ovbiagele, Bismark Osei-Bonsu et al. · 0 citations
Review Open access Oct 2026

Artificial Intelligence in the Fight Against Antimicrobial Resistance: Applications in Diagnosis, Susceptibility Prediction, Precision Dosing, and Antibiotic Discovery

Background: Antimicrobial resistance (AMR) is a major global health threat, while conventional diagnostic, stewardship, dosing, and drug-development strategies remain limited by diagnostic delays, population-level decision-making, and a shrinking antibiotic pipeline. Artificial intelligence (AI) may help address these...

Susanna Esposito, Valentina Fainardi, Gaia Giorgia Arnesano et al. · 0 citations
Review Open access Sep 2026

Clinical Decision Support for Antimicrobial Resistance Prediction and Antibiotic Prescribing: Integrating Antimicrobial Stewardship Review into the Medication-Use Pathway

Antimicrobial resistance complicates the selection of timely, effective, and appropriately narrow-spectrum antibiotic therapy. Clinical decision support systems can combine the suspected infection syndrome, illness severity, prior microbiology, recent antimicrobial exposure, local epidemiology, rapid organism identific...

Priyankar Bhooshan, V. Nisha, S. Sona et al. · 0 citations
Review Open access Sep 2026

Advancing Prediction of Antimicrobial Resistance Using Decision Tree-Based Machine Learning Approaches: A Systematic Review

Antimicrobial resistance is a growing global health threat, since it limits the effectiveness of traditional medicines and adds to the burden on health care systems and economies across the globe. Several techniques have been developed for modelling the patterns of data in a range of data sources (e.g. Random Forest, G...

Anita Agustina Styawan, Muhammad Thesa Ghozali · 0 citations
Review Open access Sep 2026

A comprehensive review of AI innovations for tackling antimicrobial resistance.

AI can certainly strengthen the global AMR response by complementing key areas of AMR such as antimicrobial stewardship, infection prevention, laboratory diagnostics, and global surveillance.

Tahani Alkalaf, E. Eker, O. Albarri et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.